Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

January 22, 2013; 80 (4) Global Perspectives

Neurology in Canada: History of the Canadian Neurological Society

T. Jock Murray, Garth Bray, Morris Freedman, A. Jon Stoessl
First published January 21, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31827f0788
T. Jock Murray
From Dalhousie University (T.J.M.), Halifax; Department of Neurology (G.B.), McGill University, Ottawa; Department of Medicine (M.F.), Division of Neurology, University of Toronto, Toronto; Division of Neurology (M.F.), Baycrest Center for Geriatric Care, Toronto; and Department of Neurology, Pacific Parkinson's Research Centre and National Parkinson Foundation Center of Excellence (A.J.S.), University of British Columbia & Vancouver Coastal Health, Vancouver, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Garth Bray
From Dalhousie University (T.J.M.), Halifax; Department of Neurology (G.B.), McGill University, Ottawa; Department of Medicine (M.F.), Division of Neurology, University of Toronto, Toronto; Division of Neurology (M.F.), Baycrest Center for Geriatric Care, Toronto; and Department of Neurology, Pacific Parkinson's Research Centre and National Parkinson Foundation Center of Excellence (A.J.S.), University of British Columbia & Vancouver Coastal Health, Vancouver, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morris Freedman
From Dalhousie University (T.J.M.), Halifax; Department of Neurology (G.B.), McGill University, Ottawa; Department of Medicine (M.F.), Division of Neurology, University of Toronto, Toronto; Division of Neurology (M.F.), Baycrest Center for Geriatric Care, Toronto; and Department of Neurology, Pacific Parkinson's Research Centre and National Parkinson Foundation Center of Excellence (A.J.S.), University of British Columbia & Vancouver Coastal Health, Vancouver, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Jon Stoessl
From Dalhousie University (T.J.M.), Halifax; Department of Neurology (G.B.), McGill University, Ottawa; Department of Medicine (M.F.), Division of Neurology, University of Toronto, Toronto; Division of Neurology (M.F.), Baycrest Center for Geriatric Care, Toronto; and Department of Neurology, Pacific Parkinson's Research Centre and National Parkinson Foundation Center of Excellence (A.J.S.), University of British Columbia & Vancouver Coastal Health, Vancouver, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Neurology in Canada: History of the Canadian Neurological Society
T. Jock Murray, Garth Bray, Morris Freedman, A. Jon Stoessl
Neurology Jan 2013, 80 (4) 406-408; DOI: 10.1212/WNL.0b013e31827f0788

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
911

Share

  • Article
  • Info & Disclosures
Loading

In the 19th and early 20th century, Canadian physicians interested in neurology focused on this area as part of their broader clinical practices. The most renowned was William Osler, often called Canada's first neurologist because one-third of his writing was devoted to neurology. Until the mid-20th century, most Canadian neurologists trained at the National Hospital, Queen Square, London, and in Paris. The majority returned to academic centers and after World War II every Canadian medical school and major center had consultant neurologists.

In 1947, Wilder Penfield at the Montreal Neurological Institute organized a meeting of Canadian neurologists and neurosurgeons that initiated the Canadian Neurological Society. A guiding precept was to bring neurologists, neurosurgeons, neuropathologists, and other clinicians focused on the nervous system together to exchange papers at a single conference. Subsequently, specialty associations of neurosurgeons, neurophysiologists, pediatric neurologists, and clinical neurophysiologists developed and, together with neurologists, became the Canadian Congress of Neurological Sciences. This became the Canadian Neurological Sciences Federation (CNSF) in 2006.

The CNSF is a legally constituted confederation of the Canadian Neurological Society, Canadian Neurosurgery Society, Canadian Association of Child Neurologists, and Canadian Society of Clinical Neurophysiologists. Organizations of neuroscience nurses, technologists, neuroscientists, and physiatrists are CNSF Associates, and 10 other related organizations focusing on neurologic diseases are CNSF Affiliates.

The principal CNSF mission is to enhance prevention, diagnosis, and management of nervous system disorders through professional development and advocacy. The CNSF promotes professional development by its annual Congress, which includes accredited continuing education courses, and publication of the Canadian Journal of Neurological Sciences. CNSF advocacy is channeled through Neurological Health Charities Canada.

Neurologic disease in Canada

In 2007, the CNSF sponsored a study by the Canadian Institute for Health Information (CIHI) on the Burden of Neurological Diseases, Disorders and Injuries in Canada.1 Total cost of 11 of the most common neurologic conditions was $8.8 billion, representing nearly 3% of direct and 9% of indirect health care costs. Neurologic conditions accounted for 10%–20% of hospital admissions, patient days in acute care, and inpatient rehabilitation, as well as disability-adjusted life-years.

The neurologic needs of the aging Canadian population will accelerate in coming years, as the life expectancy for Canadians has increased to 81 years (84.1, women; 78.2, men) and continues to rise.

Neurology training in Canada

During the last half century, most neurologists began their training in Canada, followed by a fellowship abroad. Initially fellowships were mostly at the National Hospital, Queen Square, in London, or in France. After 1965, this shifted mainly to the United States, and more recently to Canadian centers.

Before World War II, neurology training programs were located in a few centers, such as McGill and University of Toronto. Subsequently, training programs expanded to most Canadian medical schools. Since 1969, all training must be in university centers accredited by the Royal College of Physicians and Surgeons of Canada (RCPSC), which also oversees the examination of candidates for specialty certification. Provincial governments regulate the number of residency positions and provide funding for all residents. There are 16 adult and 10 child neurology training programs. The RCPSC certifies 27–30 neurologists per year. The RCPSC is also responsible for a Maintenance of Certification program requiring all specialists to earn a minimum number of continuing education credits each year. The program involves a rigorous accreditation process for providers of Continued Professional Development.

Collaborative research and educational programs

The small number of medical schools in Canada (17), and centralization of many services in major centers, encourages collaborative research and education among centers. For example, the Canadian Network of Multiple Sclerosis Centers was able to enroll over 30,000 people in a genetic study. In addition, networks of clinicians and researchers dealing with multiple sclerosis, stroke, and Parkinson disease are well-established.

Canada's role in international e-learning

Canada has a pivotal role in distance education through leadership in International Videoconference Behavioral Neurology Rounds that has involved American, Argentinian, Brazilian, Canadian, Chilean, Cuban, Israeli, Jordanian, Palestinian, Russian, South African, Spanish, and Swiss (WHO) sites. Since 2009, Canada has led the Neurology International Residents Videoconferencing Exchange (NIRVE) involving resident presentations from Brazilian, Canadian, Jordanian, and Russian centers. At the national level, Canada launched National Videoconference Neurology Grand Rounds in 2011 with participation of neurology training centers across the country.

Research funding

Neuroscience research funding comes from many sources, although primarily the Canadian Institute of Health Research (CIHR), with an annual budget of over $1 billion. Unlike the NIH, CIHR funds only extramural research. Neuroscience research accounts for about 28% of CIHR funding. Other important sources for operating support include agencies related to neurologic diseases such as multiple sclerosis, heart disease and stroke, Parkinson disease, and Alzheimer disease. Infrastructure support for major equipment and renovations comes from the Canada Foundation for Innovation. Clinical trials are primarily supported by industry, and sometimes through collaborative studies cosponsored by CIHR.

Support for principal investigators comes from universities, except in the case of industry support. However, the Canada Research Chairs, funded by the federal government, supports faculty across all disciplines, with 2,000 chairs across the country, among which neuroscience is well-represented. Some provinces have programs to support investigators relatively early in their careers. The relative lack of stable salary support has aggravated the difficulty that Canada, like many other countries, has encountered in producing significant numbers of clinician–scientists. Some universities and provinces have attempted to address this problem by introducing academic practice plans.

Neurologists and clinical practice

In Canada, there are approximately 38,000 family physicians and 35,000 specialists, of which 854 are neurologists, with 28% being women. Most are in high population areas of Ontario, Quebec, Alberta, and British Columbia. There are a maximum of 26 neurologists in each of the other 6 provinces and none in the 3 territories of Northern Canada. Approximately 44% of neurologists are over age 54 years and 20% are over age 64. Thus a significant proportion of neurologists are close to retirement age.2

Many neurologists in academic centers have multiple roles and only part of their time involves clinical practice. In 2002, 31%–49% of neurologists across the 10 provinces worked in an academic setting, 76% having subspecialty interests.3

Canada has a publicly funded health care system with coverage for all citizens and freedom of choice of physician regardless of income. Fee-for-service billing is simplified, with electronic billing for all services to the provincial government and a single payment received. There is minimal paperwork, a simplified coding system, and minimal time and overhead for the neurologist.4

Challenges for the future

The Canadian health care system must find ways to maintain the values and principles of the system while improving efficiencies and managing costs. Health care is a provincial and territorial responsibility, and since each jurisdiction has different economic pressures, responses could be less consistent and uniform in the future. Even in a health care system available to all, the access may be uneven for many rural or marginalized populations.

Almost half of the neurologists currently practicing in Canada are over age 50, with many at or beyond normal retirement age; the current numbers of residents in training will not meet the increasing needs. The aging population will bring increasing requirements for neurologic services. Waiting lists for consultations and procedures require innovative approaches and the involvement of other health care professionals. There must be a greater commitment to multidisciplinary care for chronic neurologic illnesses.

Innovative approaches will be needed to deal with a future with increased costs and demands but insufficient numbers of neurologists. Linkages and collaboration with other health professionals to provide care are essential. Canada's leadership in telehealth will be important in dealing with education, consultation, and support.

STUDY FUNDING

No targeted funding reported.

DISCLOSURE

T.J. Murray is a Scientific Advisor to the Canadian Multiple Sclerosis Monitoring System supported by the Canadian Institute for Health Information; is a Scientific Advisor on the National Population Study of Neurological Conditions; has received honoraria and travel support for lectures at conferences by Biogen Idec and Serono; and is President of the Robert Pope Foundation. G. Bray receives a stipend from the Canadian Neurological Sciences Federation. M. Freedman received funding for expenses as a delegate from the Canadian Neurological Society to the Council of Delegates of the World Congress of Neurology; has received honoraria from Novartis Pharmaceuticals Canada for advisory board consulting and Bristol Myers Squibb for attending a consultancy meeting; received financial support for a Behavioral Neurology fellow from Eli Lilly Canada; is listed on a provisional patent related to methods and kits for differential diagnosis of Alzheimer's disease vs frontotemporal dementia using blood biomarkers and may be listed on the planned patent application; receives grant funding from the Canadian Institutes of Health Research and the Parkinson Society of Canada; has received grant funding from the Alzheimer Society of Canada, Lundbeck Canada, and the Canadian Institutes of Health Research; and receives support from the Saul A. Silverman Family Foundation as a Canada International Scientific Exchange Program and Morris Kerzner Memorial Fund. A.J. Stoessl's work is supported by the Canadian Institutes of Health Research, the Michael J. Fox Foundation, the Pacific Alzheimer Research Foundation, and the Canada Research Chairs program. He has served on advisory boards or committees (unpaid) for Canada Research Chairs, the Movement Disorders Society, the Parkinson Study Group, and World Federation of Neurology Association for Parkinsonism & Related Disorders; has received speaker fees from Abbott, Medscape, and Teva; and has served as a consultant for Biogen Idec, Bioscape Imaging, Medgenesis, and Ono Pharma. Go to Neurology.org for full disclosures.

Footnotes

  • Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • © 2013 American Academy of Neurology

REFERENCES

  1. 1.↵
    Canadian Neurological Sciences Federation. The burden of neurological diseases, disorders and injuries in Canada, 2007. Available at: http://www.cnsfederation.org/advocacy.html. Accessed September 2011.
  2. 2.↵
    Canadian Medical Association. Statistical information on Canadian physicians. Available at: http://www.cma.ca/index.php?ci_id=16959&la_id=1#1. Accessed September 2011.
  3. 3.↵
    1. Bailey P,
    2. Warren S,
    3. Buske L
    . Highlights of the Canadian Neurological Society (CNS) manpower survey. Can J Neurol Sci 2005;32:425–432.
    OpenUrlPubMed
  4. 4.↵
    1. Findlay JM
    . Canadian health care explained to US colleagues: the good, the bad and the ugly. Can J Neurol Sci 2010;37:310–312.
    OpenUrlPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • STUDY FUNDING
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • Warfarin treatment and thrombolysisHow to persuade procrastinators?
  • tPA and warfarinTime to move forward
  • Neighborhood socioeconomic status and stroke mortalityDisentangling individual and area effects
  • The border-land of epilepsy—Revisited
  • Diagnostic shifts in ALS?From clinical specter to imaging spectra
  • Biomarkers for PDHow can we approach complexity?
  • Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS
  • Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease

Topics Discussed

  • All Health Services Research
  • All Education
  • Methods of education

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Hospital volume and stroke outcome
    Does it matter?
    G. Saposnik, A. Baibergenova, M. O'Donnell et al.
    Neurology, July 18, 2007
  • Historical Neurology
    J. Clifford Richardson and 50 years of progressive supranuclear palsy
    David R. Williams, Andrew J. Lees, John R. Wherrett et al.
    Neurology, February 11, 2008
  • Articles
    Gender differences in carotid imaging and revascularization following stroke
    M. K. Kapral, M. Ben-Yakov, J. Fang et al.
    Neurology, December 07, 2009
  • Articles
    Risk of premature stroke in recent immigrants (PRESARIO)
    Population-based matched cohort study
    G. Saposnik, D. A. Redelmeier, H. Lu et al.
    Neurology, February 03, 2010
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise